The effect of fecal microbiota transplantation on Hepatic myelopathy: A case report.

ABSTRACT:

Rationale

Hepatic myelopathy (HM), also known as portal-systemic myelopathy, is a rare neurological complication that occurs in patients with chronic liver disease. There is no easy and feasible treatment, liver transplantation is the only accepted therapy that may be effective for patients at early stage at present. The pathogenesis of the disease is not clear yet, and the prognosis is poor. Here we describe a reversible HM after fecal microbiota transplantation.

Patient concerns

In this report, a middle-aged female patient with hepatitis B cirrhosis, occurred HM after transjugular intrahepatic portosystemic shunt, a progressive spastic paraparesis in both legs were the main symptoms.

Diagnosis

The patient was diagnosed with HM.

Interventions

The patient recei

SUBMITTER: Sun L 

PROVIDER: S-EPMC6641758 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature